X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
oncology (13) 13
index medicus (12) 12
radiotherapy (11) 11
germany (10) 10
dermatology - standards (8) 8
medical oncology - standards (8) 8
medicine & public health (8) 8
practice guidelines as topic (8) 8
skin neoplasms - diagnosis (8) 8
skin neoplasms - therapy (8) 8
male (7) 7
female (6) 6
cancer (5) 5
care and treatment (5) 5
child (5) 5
follow-up studies (5) 5
therapy (5) 5
adolescent (4) 4
combined modality therapy (4) 4
middle aged (4) 4
radiology, nuclear medicine & medical imaging (4) 4
research (4) 4
adult (3) 3
aged (3) 3
chemotherapy (3) 3
children (3) 3
dermatology - trends (3) 3
dna methylation (3) 3
health aspects (3) 3
medical oncology - trends (3) 3
patients (3) 3
prospective studies (3) 3
radiation therapy (3) 3
risk factors (3) 3
analysis (2) 2
antineoplastic agents - pharmacology (2) 2
anxiety (2) 2
azacitidine - analogs & derivatives (2) 2
azacitidine - pharmacology (2) 2
bevacizumab (2) 2
brain (2) 2
brain neoplasms - mortality (2) 2
carcinoma, basal cell - diagnosis (2) 2
carcinoma, basal cell - therapy (2) 2
carcinoma, squamous cell - diagnosis (2) 2
carcinoma, squamous cell - therapy (2) 2
cell line, tumor (2) 2
cell proliferation - drug effects (2) 2
cerebellar neoplasms - genetics (2) 2
childhood (2) 2
colleges & universities (2) 2
depression (2) 2
dermatofibrosarcoma - diagnosis (2) 2
dermatofibrosarcoma - therapy (2) 2
disease (2) 2
disease-free survival (2) 2
dose-response relationship, drug (2) 2
epigenesis, genetic - drug effects (2) 2
expression (2) 2
genetics (2) 2
glioblastoma (2) 2
glioblastoma - drug therapy (2) 2
glioblastoma - mortality (2) 2
glioblastoma - pathology (2) 2
glioblastoma multiforme (2) 2
glioma (2) 2
hematology (2) 2
hospitals (2) 2
irradiation (2) 2
kaplan-meier estimate (2) 2
late sequelae (2) 2
lymphoma (2) 2
medulloblastoma (2) 2
medulloblastoma - genetics (2) 2
neoplasm grading (2) 2
organ dose levels (2) 2
quality-of-life (2) 2
radiation (2) 2
radiation injuries - etiology (2) 2
retrospective studies (2) 2
surgery (2) 2
survival (2) 2
temozolomide (2) 2
treatment outcome (2) 2
tretinoin - pharmacology (2) 2
tumors (2) 2
valproic acid (2) 2
valproic acid - pharmacology (2) 2
young adult (2) 2
5-aza-2 '-deoxycytidine (1) 1
5-aza-2'-deoxycytidine (1) 1
5-aza-2’-deoxycytidine (1) 1
abacavir (1) 1
abdominal neoplasms - radiotherapy (1) 1
abridged index medicus (1) 1
age factors (1) 1
animals (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1100 - 1108
Journal Article
The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10172, pp. 678 - 688
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 06/2019, Volume 17, Issue 6, pp. 663 - 668
Zusammenfassung Das Dermatofibrosarcoma protuberans (DFSP) ist eine sehr seltene Tumorentität. Nichtsdestotrotz stellt es das häufigste kutane Sarkom dar. Das... 
Platelet-derived growth factor
Journal Article
Journal Article
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 06/2016, Volume 35, Issue 1, p. 94
Background: Medulloblastoma (MB) is the most common pediatric brain tumor. Current treatment regimes consisting of primary surgery followed by radio-and... 
PROGENITOR CELLS | CANCER-CELLS | STEM-CELLS | DNA METHYLATION | ONCOLOGY | SUBEROYLANILIDE HYDROXAMIC ACID | TUMOR-SUPPRESSOR GENES | CYCLE ARREST | RHABDOID TUMOR | VALPROIC ACID | TRANS-RETINOIC ACID | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Stilbenes - administration & dosage | Humans | Epigenesis, Genetic - radiation effects | Antineoplastic Agents - administration & dosage | Stilbenes - pharmacology | Valproic Acid - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Medulloblastoma - radiotherapy | Radiation-Sensitizing Agents - administration & dosage | Hydroxamic Acids - administration & dosage | Neurogenesis - radiation effects | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Neurogenesis - drug effects | Medulloblastoma - genetics | Hydroxamic Acids - pharmacology | Azacitidine - administration & dosage | Tretinoin - pharmacology | Cell Differentiation - radiation effects | Dideoxynucleosides - administration & dosage | Cell Survival - drug effects | Dideoxynucleosides - pharmacology | Cerebellar Neoplasms - drug therapy | Tretinoin - administration & dosage | Radiation-Sensitizing Agents - pharmacology | Azacitidine - analogs & derivatives | Treatment Outcome | Combined Modality Therapy | Cerebellar Neoplasms - genetics | Cell Survival - radiation effects | Xenograft Model Antitumor Assays | Azacitidine - pharmacology | Animals | Valproic Acid - administration & dosage | Cell Differentiation - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Medulloblastoma - drug therapy | Cerebellar Neoplasms - radiotherapy | Cell Proliferation - radiation effects | Complications and side effects | Care and treatment | Ionizing radiation | Medulloblastoma | Research | Metastasis | Health aspects | Risk factors
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 2013, Volume 32, Issue 1, pp. 27 - 27
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 03/2006, Volume 4, Issue 3, pp. 260 - 262
Journal Article